Expect patient care to suffer when physicians face a 2.8% decrease in reimbursement in 2025, even as regulators acknowledge practice costs are going up.
The proposed meager Medicare reimbursement increase for dialysis providers marks the fifth year in a row that the agency has failed to capture actual increases in labor and treatment costs.
In theory, patients should benefit from drug price discounts negotiated between drug companies and insurers. In reality, they don’t, and a potential solution is stalled in Congress.